Clinical Trial: Efficacy and Safety of Lenalidomide as a Treatment for Recurrent or Refractory POEMS Syndrome Trial

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Single Arm Open-label Trial to Investigate the Efficacy and Safety of Lenlidomide as a Treatment for Recurrent or Refractory Crow-Fukase (POEMS) Syndrome

Brief Summary: This study investigates the efficacy and safety of Lenalidomide as a treatment for recurrent or refractory POEMS (Crow-Fukase) syndrome.

Detailed Summary: This study investigates the efficacy and safety of Lenalidomide as a treatment for recurrent /refractory POEMS (Crow-Fukase) syndrome.
Sponsor: Chiba University

Current Primary Outcome: Reduction rate of serum VEGF [ Time Frame: after 24 weeks ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Chiba University

Dates:
Date Received: July 16, 2014
Date Started: July 2014
Date Completion:
Last Updated: July 27, 2016
Last Verified: July 2016